Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial	Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, pregnancy disorder, pregnancy disorder with abortive outcome	Recruiting	Phase 3	2026-04-09		NCT06980025

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Columbia University	375
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	536
The George Washington University Biostatistics Center	6

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baylor College of Medicine	Houston	United States	306
Brown University	Providence	United States	2
Case Western Reserve University	Cleveland	United States	3
Columbia University	New York	United States	154
Duke University	Durham	United States	160
Hospital of the University of Pennsylvania	Philadelphia	United States	142
Magee Women's Hospital of UPMC	Pittsburgh	United States	6
Northwestern University	Chicago	United States	727
Ohio State University	Columbus	United States	169
Regents of the University of California San Francisco	San Francisco	United States	4
University of Alabama - Birmingham	Birmingham	United States	6
University of North Carolina - Chapel Hill	Chapel Hill	United States	10
University of Texas - Houston	Houston	United States	6
University of Utah Medical Center	Salt Lake City	United States	5